Clinical trial

The Influence of Topical Menthol Gel on Thermoregulatory and Perceptual Outcomes During Exercise Within the Heat

Name
0111-22-FB
Description
The purpose of this study is to examine the human thermoregulatory impact of applying a commercially available menthol gel (BioFreeze) to the skin prior to moderate intensity walking under heated conditions. Experimental Visits will consist of 30 min of treadmill walking at a moderate pace (3.5 mph, 5% grade) under hot conditions (38°C, 60%RH) and will be randomized and counterbalanced for BioFreeze or a hypoallergenic gel (control) application. Gels will be applied to areas commonly exposed during outdoor activity in warm conditions (shoulder to wrist, mid thigh to ankle). Accordingly, participants will wear shorts and a tank top shirt during exercise. Core temperature, skin temperature, galvanic skin response, laser doppler blood flow, and heart rate will be continuously recorded throughout the exercise bout via an integrated analog to digital converter. Sweat will be collected during exercise using commercially available absorbent patches. Thermal sensation will be assessed throughout exercise via the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) thermal sensation likert scale (cold to hot). Lastly, nude body weight will be recorded pre and post exercise for sweat rate determination. The BioFreeze and control trials will be separated by a 7-14 day washout period.
Trial arms
Trial start
2022-05-01
Estimated PCD
2022-10-01
Trial end
2022-10-01
Status
Completed
Phase
Early phase I
Treatment
Menthol Gel
5% menthol gel applied from shoulder to wrist and mid thigh to ankle, 30 minute treadmill walk (3.5 mph at 5% grade at 38°C, 60% relative humidity)
Arms:
Hypoallergenic Gel first, then menthol, Menthol Gel first, then hypoallergenic gel
Other names:
BioFreeze
Control Gel
Hypoallergenic gel applied from shoulder to wrist and mid thigh to ankle, 30 minute treadmill walk (3.5 mph at 5% grade at 38°C, 60% relative humidity)
Arms:
Hypoallergenic Gel first, then menthol, Menthol Gel first, then hypoallergenic gel
Other names:
placebo
Size
12
Primary endpoint
Skin Blood Flow
10 minutes into exercise bout
Skin Blood Flow
30 minutes into exercise bout
Galvanic Skin Response
Time to 40 micro-siemens
Sweat Composition
final 10 minutes of exercise bout
Sweat Rate
pre to post exercise, approximately 30 minutes
Thermal Perception
throughout the 30 minute exercise bout
Average Skin Temperature
after 30 minutes of exercise
Core Temperature
after 30min exercise
Sweat Potassium Concentration
final 10 minutes of the exercise bout
Eligibility criteria
Inclusion Criteria: * 19-45 years of age * cleared for physical activity via the 2022 physical activity readiness questionnaire (PARQ) * no self-reported adverse reactions to menthol based gels Exclusion Criteria: * outside 19-45 years of age * not cleared for physical activity via the 2022 physical activity readiness questionnaire (PARQ) * self-report or signs of sensitivity to menthol gels * pregnant * breast feeding
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'CROSSOVER', 'interventionModelDescription': 'Each Subject acts as their own control in a repeated measures design', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 12, 'type': 'ACTUAL'}}
Updated at
2024-04-24

1 organization

2 products

2 indications

Product
Menthol
Indication
Acute Exercise
Indication
Heat Exposure
Product
Control